NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080220189

Registered date:19/12/2005

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedPatients with Crohn's disease in active phase
Date of first enrollment19/12/2005
Target sample size
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : Z-206 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary OutcomeRemission induction rate
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
Gender
Include criteriaPatients with Crohn's disease in active phase who are defined to show CDAI of 150 or higher but less than 250, and whose lesion is mainly observed at the end of ileum or lower part.
Exclude criteria

Related Information

Contact

Public contact
Name
Address kaihatu@zeria.co.jp
Telephone
E-mail
Affiliation ZERIA Pharmaceutical Co.,Ltd
Scientific contact
Name
Address
Telephone
E-mail
Affiliation